Concepedia

Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy

Laura Cicconi, Massimo Breccia, Luca Franceschini, Roberto Latagliata, Matteo Molica, Mariadomenica Divona, Daniela Diverio, Manuela Rizzo, Tiziana Ottone, Licia Iaccarino,

Annals of Hematology · 2018 · 26 citations · 14 references

DOI

Concepts

References

14

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

Alan K. Burnett, Nigel H. Russell, Robert K. Hills et al. · The Lancet Oncology · 2015 · 533 citations

, , +8

Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti et al. · Blood · 2010 · 340 citations

AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance

Giuseppe Avvisati, Francesco Lo‐Coco, Francesca Paoloni et al. · Blood · 2011 · 186 citations · Full text

Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia

Masamitsu Yanada, Motohiro Tsuzuki, Hiroyuki Fujita et al. · Blood · 2013 · 78 citations